Middle Eastern Expert Opinion: Strategies for Successful Antifungal Stewardship Program Implementation in Invasive Fungal Infections.

antifungal stewardship antifungal use knowledge multidisciplinary resistance therapeutic drug monitoring

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
May 2024
Historique:
accepted: 23 05 2024
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 26 6 2024
Statut: epublish

Résumé

In recent years, global public health efforts have increasingly emphasized the critical role of antimicrobial stewardship (AMS) in improving outcomes, reducing costs, and combating the growing threat of antimicrobial resistance. However, antifungal stewardship (AFS) has remained relatively overlooked despite the staggering impact of invasive fungal infections (IFIs). This burden is particularly pronounced in hospitals worldwide, with the Middle East facing significant unmet needs. The rising population of immunocompromised individuals vulnerable to IFI has prompted an increased reliance on antifungal agents for both prevention and treatment. Given the considerable mortality associated with IFIs and the emergence of antifungal resistance, implementing AFS programs in hospital settings is becoming increasingly urgent. In this article, we offer expert insights into the strategies that can be used for successful antifungal stewardship program implementation in IFI. Drawing upon the extensive clinical experience of a multinational and multidisciplinary panel, we present recommendations for optimizing AFS practices. We delve into the challenges and practical considerations of tailoring local AFS initiatives to the evolving landscape of fungal infections. Additionally, we provide actionable recommendations and position statements for the effective implementation of AFS programs, informed by the collective clinical experiences of panel members across their respective countries of practice.

Identifiants

pubmed: 38919246
doi: 10.7759/cureus.61127
pmc: PMC11198984
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e61127

Informations de copyright

Copyright © 2024, Alsalman et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Jameela Alsalman (J)

Medicine, Arabian Gulf University, Manama, BHR.

Abdulhakeem Althaqafi (A)

College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Infectious Diseases, King Abdullah International Medical Research Center, Jeddah, SAU.
Department of Medicine/Infectious Diseases, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, SAU.

Ahmad Alsaeed (A)

College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Adult Hematology and Stem Cell Transplantation, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of the National Guard Health Affairs, Jeddah, SAU.

Ahmad Subhi (A)

Adult Infectious Diseases, Department of Medicine, Al-Qassimi Hospital, Emirates Health Services, Sharjah, ARE.

Ahmed F Mady (AF)

Critical Care Medicine, King Saud Medical City, Riyadh, SAU.

Ayman AlHejazi (A)

Department of Oncology, King Abdulaziz Medical City Riyadh, Riyadh, SAU.
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.

Bassam Francis (B)

Hematology, Hematology and Bone Marrow Transplant Center, Baghdad, IRQ.

Hanan H Alturkistani (HH)

Transplant Infectious Diseases, King Abdullah Medical City, Makkah, SAU.

Mouhab Ayas (M)

Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, SAU.

Montaser Bilbisi (M)

Department of Infectious Diseases, Abdali Medical Center, Amman, JOR.

Sondus Alsharidah (S)

Pediatric Stem Cell Transplant Unit, Department of Pediatric Hematology/Oncology, National Bank of Kuwait (NBK) Children's Specialized Hospital, Sabah Central Health Region, KWT.

Classifications MeSH